← All organizations

High Impact Clinical Research Support Program

Academic/Hospital

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

May 1, 2016

Timeline

No events for the selected filters.

Drugs by trial phase (7 distinct, 4 trials)

Phase 2 (1 own, 0 via acquisition)

cabozantinib

Phase 1 (6 own, 0 via acquisition)

Indications

Studied for

Recent trials (4)

NCT02652871CollaboratorPhase 1May 1, 2016
NCT02210117CollaboratorEarly Phase 1Nov 1, 2014
NCT02113657CollaboratorEarly Phase 1Aug 1, 2014
NCT01630590CollaboratorPhase 2Jan 8, 2014

Details

Last known activity: May 1, 2016